Summary of Clinigen Group Plc (LON:CLIN) Ratings

May 17, 2018 - By Stacey Dunning

Clinigen Group Plc (LON:CLIN) Corporate Logo

Clinigen Group Plc (LON:CLIN) Ratings Coverage

Total analysts of 4 have positions in Clinigen Group (LON:CLIN) as follows: 4 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since November 29, 2017 according to StockzIntelligence Inc Clinigen Group has 12 analyst reports. In Wednesday, November 29 report N+1 Singer reinitiated the stock with “Buy” rating. On Wednesday, January 17 Numis Securities maintained the shares of CLIN in report with “Add” rating. The stock rating was maintained by Berenberg with “Buy” on Tuesday, March 27. On Thursday, February 1 Peel Hunt maintained Clinigen Group Plc (LON:CLIN) rating. Peel Hunt has “Buy” rating and GBX 1350 target. On Tuesday, February 27 the rating was maintained by Numis Securities with “Add”. On Tuesday, February 27 the firm has “Buy” rating given by Peel Hunt. The company rating was maintained by Peel Hunt on Wednesday, January 17. On Thursday, March 1 the rating was maintained by Peel Hunt with “Buy”. On Monday, March 19 the firm has “Buy” rating given by Peel Hunt. In Thursday, January 18 report Berenberg upgraded it to “Buy” rating and GBX 1220 target. Listed here are Clinigen Group Plc (LON:CLIN) PTs and latest ratings.

04/04/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 Maintain
27/03/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1220.00 New Target: GBX 1160.00 Reiteration
19/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
01/03/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
27/02/2018 Broker: Numis Securities Rating: Add Old Target: GBX 1208.00 New Target: GBX 1208.00 Maintain
27/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
01/02/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain
18/01/2018 Broker: Berenberg Rating: Buy Old Target: GBX 1200.00 New Target: GBX 1220.00 Upgrade
17/01/2018 Broker: N+1 Singer Rating: Buy Old Target: GBX 1225.00 New Target: GBX 1225.00 Maintain
17/01/2018 Broker: Peel Hunt Rating: Buy Old Target: GBX 1350.00 New Target: GBX 1350.00 Maintain

CLIN is hitting GBX 864 during the last trading session, after decreased 0.17%.Currently Clinigen Group Plc is after 0.00% change in last May 17, 2017. CLIN has also 68,219 shares volume. The stock underperformed the S&P 500 by 11.55%.

Clinigen Group plc operates as a specialty pharmaceutical and services firm in the United Kingdom, Europe, the United States, and internationally.The company has 1.06 billion GBP market cap. The Company’s Clinigen Clinical Trial Services business supplies and manages commercial medical products, including comparator drugs, adjuvant drugs, and rescue therapies for patients in clinical trials, as well as provides value added services.The P/E ratio is 77.14. The companyÂ’s Idis Managed Access business is involved in the consultancy, development, management, and implementation of managed access programs for biotechnology and pharmaceutical companies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.